Revisión bibliográfica: caracterización aspectos clínicos y tratamiento de pacientes con vitíligo
DOI:
https://doi.org/10.34119/bjhrv6n1-110Keywords:
vitíligo, tratamiento, dermatologíaAbstract
El vitíligo es una enfermedad autoinmune que da como resultado la despigmentación de la piel, generando un importante impacto en el estilo de vida y la autoestima de quienes lo padecen. Por estas razones muchos pacientes en su afán de ver resultados permanentes optan por la aplicación de tratamientos con pocas o ninguna base científica, siendo víctimas de la propaganda engañosa o promesas milagrosas de productos de dudosa procedencia. El presentar artículo de revisión bibliográfica busca resumir los datos más importantes en torno a la enfermedad, desde su epidemiologia, fisiopatología y clínica hasta profundizar en las opciones terapéuticas mas importantes.
References
Baldini, E., Odorisio, T., Sorrenti, S., Catania, A., Tartaglia, F., Carbotta, G., Pironi, D., Rendina, R., D’Armiento, E., Persechino, S., & Ulisse, S. (2017). Vitiligo and Autoimmune Thyroid Disorders. Frontiers in Endocrinology, 8, 290. https://doi.org/10.3389/fendo.2017.00290
Binder, R. J., Zhou, Y. J., Messmer, M. N., & Pawaria, S. (2012). CD91-Dependent Modulation of Immune Responses by Heat Shock Proteins: A Role in Autoimmunity. Autoimmune Diseases, 2012, 863041. https://doi.org/10.1155/2012/863041
Denman, C. J., McCracken, J., Hariharan, V., Klarquist, J., Oyarbide-Valencia, K., Guevara-Patiño, J. A., & Le Poole, I. C. (2008). HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo. The Journal of Investigative Dermatology, 128(8), 2041-2048. https://doi.org/10.1038/jid.2008.45
Ezzedine, K., Eleftheriadou, V., Whitton, M., & van Geel, N. (2015). Vitiligo. Lancet (London, England), 386(9988), 74-84. https://doi.org/10.1016/S0140-6736(14)60763-7
Ezzedine, K., Lim, H. W., Suzuki, T., Katayama, I., Hamzavi, I., Lan, C. C. E., Goh, B. K., Anbar, T., de Castro, C. S., Lee, A. Y., Parsad, D., van Geel, N., Le Poole, I. C., Oiso, N., Benzekri, L., Spritz, R., Gauthier, Y., Hann, S. K., Picardo, M., & Taieb, A. (2012). Revised classification/nomenclature of vitiligo and related issues: The Vitiligo Global Issues Consensus Conference. Pigment cell & melanoma research, 25(3), E1-13. https://doi.org/10.1111/j.1755-148X.2012.00997.x
Faas, L., Venkatasamy, R., Hider, R. C., Young, A. R., & Soumyanath, A. (2008). In vivo evaluation of piperine and synthetic analogues as potential treatments for vitiligo using a sparsely pigmented mouse model. The British Journal of Dermatology, 158(5), 941-950. https://doi.org/10.1111/j.1365-2133.2008.08464.x
Gey, A., Diallo, A., Seneschal, J., Léauté-Labrèze, C., Boralevi, F., Jouary, T., Taieb, A., & Ezzedine, K. (2013). Autoimmune thyroid disease in vitiligo: Multivariate analysis indicates intricate pathomechanisms. The British Journal of Dermatology, 168(4), 756-761. https://doi.org/10.1111/bjd.12166
Goh, B.-K., & Pandya, A. G. (2017). Presentations, Signs of Activity, and Differential Diagnosis of Vitiligo. Dermatologic Clinics, 35(2), 135-144. https://doi.org/10.1016/j.det.2016.11.004
Gong, Q., Li, X., Sun, J., Ding, G., Zhou, M., Zhao, W., & Lu, Y. (2015). The effects of calcipotriol on the dendritic morphology of human melanocytes under oxidative stress and a possible mechanism: Is it a mitochondrial protector? Journal of Dermatological Science, 77(2), 117-124. https://doi.org/10.1016/j.jdermsci.2014.12.006
Gorovoy, M., Gaultier, A., Campana, W. M., Firestein, G. S., & Gonias, S. L. (2010). Inflammatory mediators promote production of shed LRP1/CD91, which regulates cell signaling and cytokine expression by macrophages. Journal of Leukocyte Biology, 88(4), 769-778. https://doi.org/10.1189/jlb.0410220
Grimes, P. E., Hamzavi, I., Lebwohl, M., Ortonne, J. P., & Lim, H. W. (2013). The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo. JAMA Dermatology, 149(1), 68-73. https://doi.org/10.1001/2013.jamadermatol.386
Guerra, L., Primavera, G., Raskovic, D., Pellegrini, G., Golisano, O., Bondanza, S., Paterna, P., Sonego, G., Gobello, T., Atzori, F., Piazza, P., Luci, A., & De Luca, M. (2003). Erbium:YAG laser and cultured epidermis in the surgical therapy of stable vitiligo. Archives of Dermatology, 139(10), 1303-1310. https://doi.org/10.1001/archderm.139.10.1303
Iannella, G., Greco, A., Didona, D., Didona, B., Granata, G., Manno, A., Pasquariello, B., & Magliulo, G. (2016). Vitiligo: Pathogenesis, clinical variants and treatment approaches. Autoimmunity Reviews, 15(4), 335-343. https://doi.org/10.1016/j.autrev.2015.12.006
Kim, S. R., Heaton, H., Liu, L. Y., & King, B. A. (2018). Rapid Repigmentation of Vitiligo Using Tofacitinib Plus Low-Dose, Narrowband UV-B Phototherapy. JAMA Dermatology, 154(3), 370-371. https://doi.org/10.1001/jamadermatol.2017.5778
Komnitski, M., Komnitski, A., Komnitski Junior, A., & Silva de Castro, C. C. (2020). Partial repigmentation of vitiligo with tofacitinib, without exposure to ultraviolet radiation. Anais Brasileiros de Dermatologia, 95(4), 473-476. https://doi.org/10.1016/j.abd.2019.08.032
Lee, J. H., Kwon, H. S., Jung, H. M., Lee, H., Kim, G. M., Yim, H. W., & Bae, J. M. (2019). Treatment Outcomes of Topical Calcineurin Inhibitor Therapy for Patients With Vitiligo: A Systematic Review and Meta-analysis. JAMA Dermatology, 155(8), 929-938. https://doi.org/10.1001/jamadermatol.2019.0696
Lin, Z., Hoult, J. R., Bennett, D. C., & Raman, A. (1999). Stimulation of mouse melanocyte proliferation by Piper nigrum fruit extract and its main alkaloid, piperine. Planta Medica, 65(7), 600-603. https://doi.org/10.1055/s-1999-14031
Lin, Z., Liao, Y., Venkatasamy, R., Hider, R. C., & Soumyanath, A. (2007). Amides from Piper nigrum L. with dissimilar effects on melanocyte proliferation in-vitro. The Journal of Pharmacy and Pharmacology, 59(4), 529-536. https://doi.org/10.1211/jpp.59.4.0007
Lu, T., Gao, T., Wang, A., Jin, Y., Li, Q., & Li, C. (2007). Vitiligo prevalence study in Shaanxi Province, China. International Journal of Dermatology, 46(1), 47-51. https://doi.org/10.1111/j.1365-4632.2006.02848.x
Manolache, L., Petrescu-Seceleanu, D., & Benea, V. (2009). Correlation of stressful events with onset of vitiligo in children. Journal of the European Academy of Dermatology and Venereology: JEADV, 23(2), 187-188. https://doi.org/10.1111/j.1468-3083.2008.02764.x
Norris, D. A., Kissinger, R. M., Naughton, G. M., & Bystryn, J. C. (1988). Evidence for immunologic mechanisms in human vitiligo: Patients’ sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular
Mosenson, J. A., Eby, J. M., Hernandez, C., & Le Poole, I. C. (2013). A CENTRAL ROLE FOR INDUCIBLE HEAT SHOCK PROTEIN 70 IN AUTOIMMUNE VITILIGO. Experimental dermatology, 22(9), 566-569. https://doi.org/10.1111/exd.12183
Mosenson, J. A., Eby, J. M., Hernandez, C., & Le Poole, I. C. (2013). A central role for inducible heat-shock protein 70 in autoimmune vitiligo. Experimental Dermatology, 22(9), 566-569. https://doi.org/10.1111/exd.12183
Rashighi, M., Agarwal, P., Richmond, J. M., Harris, T. H., Dresser, K., Su, M.-W., Zhou, Y., Deng, A., Hunter, C. A., Luster, A. D., & Harris, J. E. (2014). CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo. Science Translational Medicine, 6(223), 223ra23. https://doi.org/10.1126/scitranslmed.3007811
Richmond, J. M., Frisoli, M. L., & Harris, J. E. (2013). Innate immune mechanisms in vitiligo: Danger from within. Current Opinion in Immunology, 25(6), 676-682. https://doi.org/10.1016/j.coi.2013.10.010
Rodrigues, M., Ezzedine, K., Hamzavi, I., Pandya, A. G., Harris, J. E., & Vitiligo Working Group. (2017). New discoveries in the pathogenesis and classification of vitiligo. Journal of the American Academy of Dermatology, 77(1), 1-13. https://doi.org/10.1016/j.jaad.2016.10.048
Salzer, B. A., & Schallreuter, K. U. (1995). Investigation of the personality structure in patients with vitiligo and a possible association with impaired catecholamine metabolism. Dermatology (Basel, Switzerland), 190(2), 109-115. https://doi.org/10.1159/000246657
Sasaki, M., Kondo, M., Sato, K., Umeda, M., Kawabata, K., Takahashi, Y., Suzuki, T., Matsunaga, K., & Inoue, S. (2014). Rhododendrol, a depigmentation-inducing phenolic compound, exerts melanocyte cytotoxicity via a tyrosinase-dependent mechanism. Pigment Cell & Melanoma Research, 27(5), 754-763. https://doi.org/10.1111/pcmr.12269
Sehgal, V. N., & Srivastava, G. (2007). Vitiligo: Compendium of clinico-epidemiological features. Indian Journal of Dermatology, Venereology and Leprology, 73(3), 149-156. https://doi.org/10.4103/0378-6323.32708
Shafiee, A., Hoormand, M., Shahidi-Dadras, M., & Abadi, A. (2018). The effect of topical piperine combined with narrowband UVB on vitiligo treatment: A clinical trial study. Phytotherapy Research: PTR, 32(9), 1812-1817. https://doi.org/10.1002/ptr.6116
Soumyanath, A., Venkatasamy, R., Joshi, M., Faas, L., Adejuyigbe, B., Drake, A. F., Hider, R. C., & Young, A. R. (2006). UV irradiation affects melanocyte stimulatory activity and protein binding of piperine. Photochemistry and Photobiology, 82(6), 1541-1548.
Spritz, R. A. (2008). The genetics of generalized vitiligo. Current Directions in Autoimmunity, 10, 244-257. https://doi.org/10.1159/000131501
Taïeb, A., Picardo, M., & VETF Members. (2007). The definition and assessment of vitiligo: A consensus report of the Vitiligo European Task Force. Pigment Cell Research, 20(1), 27-35. https://doi.org/10.1111/j.1600-0749.2006.00355.x
Yaghoobi, R., Omidian, M., & Bagherani, N. (2011). Vitiligo: A review of the published work. The Journal of Dermatology, 38(5), 419-431. https://doi.org/10.1111/j.1346-8138.2010.01139.x
